cpa residue levels in consecutive c48 cases of oriental ... · procedure izmir oriental tobacco...
TRANSCRIPT
CPA Residue Levels in Consecutive C48 Cases
of Oriental Tobacco Heather Westberg and Andrae Spencer
Global Laboratory Services, Inc.
CORESTA AP 2015
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Background
Crop Protection Agents (CPA) may be applied at various stages of the tobacco growing cycle and if CPA residues are present in the tobacco, outside of product standards, they could be a topic of concern.
After tobacco is processed it is normally packed into cases or bales for shipment. The packing stage is a common point where tobacco samples are collected for CPA residue analysis.
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Objective
The objective of the study was to determine the homogeneity of CPA residues throughout the case, as well as across cases.
Three consecutive production run cases were sampled at multiple positions within the case and analyzed for CPA residue levels to measure variability within and between cases.
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Procedure
Izmir Oriental tobacco type was chosen for this study.
Three consecutively produced cases were supplied by Socotab Yaprak Tutun.
The cases were sampled using a Hydraulic Thief sample press.
Each case had 10 samples collected from the top, after which the case was inverted and 10 samples were taken from the bottom.
Each sample was tested in triplicate for common CPA residues.
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Sampling Diagram
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
A C48 Case
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
A C48 Case out of the box
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
In the press
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
During Sampling
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
After Sampling
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Results Case 1 Mean
Case 2 Mean
Case 3 Mean
Sample Range
GRAND MEAN
Thiamethoxam (ppm) Top 0.21 0.18 0.26
Bottom 0.19 0.21 0.29 Case mean of
means 0.20 0.20 0.27 0.11 - 0.56
(5.1X) 0.22
Imidacloprid Top 0.57 0.60 0.50
Bottom 0.54 0.62 0.62 Case mean of
means 0.56 0.61 0.56 0.25 - 0.93
(3.7X) 0.58
Acetamiprid Top 0.16 0.14 0.07
Bottom 0.15 0.17 0.09 Case mean of
means 0.15 0.16 0.08 0.02 - 0.30
(15X) 0.13
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Results Case 1 Mean
Case 2 Mean
Case 3 Mean
Sample Range
GRAND MEAN
Metalaxyl (ppm) Top 0.49 0.45 0.46
Bottom 0.49 0.64 0.47 Case mean of
means 0.49 0.54 0.47 0.30 - 0.87
(2.9X) 0.50
Dimethomorph Top 0.30 0.34 0.24
Bottom 0.25 0.25 0.37 Case mean of
means 0.28 0.29 0.30 0.10 -0.69 (6.9X) 0.29
Penconazole Top 0.31 0.35 0.36
Bottom 0.34 0.35 0.35 Case mean of
means 0.33 0.35 0.36 0.16 -0.54
(3.4X) 0.35
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Statistical Analyses
Statistical analyses were performed using StatGraphics Centurion XV, StatPoint Technologies, Inc.
A One-Way Analysis of Variance (ANOVA) was used to determine differences between groups of means. The ANOVA decomposes the variance of the analyte into two components: between-groups and within-groups.
Next, a multiple range test was used to determine which means were significantly different from each other at the 95% confidence level. The Tukey's honest significant difference (HSD) was used to discriminate among the means. With this method, there is a 5.0% risk of calling one or more pairs significantly different when their actual difference equals 0.
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
• Two groups were identified • Case 3 is statistically different
Case I Case 2 Case 3
Means and 95.0 Percent Confidence Intervals (internal s)
0.17
0.2
0.23
0.26
0.29
0.32
Thia
met
hoxa
m (p
pm)
Results – Thiamethoxam Cases Grand Mean Comparison
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
• One group was identified • Unable to statistically differentiate between cases
Imidacloprid Cases Grand Mean Comparison
Case I Case 2 Case 3
Means and 95.0 Percent Confidence Intervals (internal s)
0.51
0.54
0.57
0.6
0.63
0.66
Imid
aclo
prid
(ppm
)
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
• Two groups were identified • Case 3 is statistically
Acetamiprid Cases Grand Mean Comparison
Case I Case 2 Case 3
Means and 95.0 Percent Confidence Intervals (internal s)
0.066
0.086
0.106
0.126
0.146
0.166
Ace
tam
ipri
d (p
pm)
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
• Two groups were identified • Case 2 is statistically different
Metalaxyl Cases Grand Mean Comparison
Case I Case 2 Case 3
Means and 95.0 Percent Confidence Intervals (internal s)
0.43
0.46
0.49
0.52
0.55
0.58
Met
alax
yl (p
pm)
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
• One group was identified • Unable to statistically differentiate between cases
Dimethomorph Cases Grand Mean Comparison
Case I Case 2 Case 3
Means and 95.0 Percent Confidence Intervals (internal s)
0.25
0.27
0.29
0.31
0.33
0.35
Dim
etho
mor
ph (p
pm)
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
• One group was identified • Unable to statistically differentiate between cases
Penconazole Cases Grand Mean Comparison
Case I Case 2 Case 3
Means and 95.0 Percent Confidence Intervals (internal s)
0.3
0.32
0.34
0.36
0.38
Penc
onaz
ole
(ppm
)
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Summary
All measured residues were well below their respective CORESTA GRL values.
The CPA residues results within each case were not homogenous throughout the case based on the 20 locations sampled.
Some of the consecutive cases were observed to have statistically different CPA residue levels.
The individual sample’s measured residue levels, from lowest to highest result for a given CPA, ranged from 2.9X to 15X
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Conclusions
Results based on a single sample location may not be representative of the entire case, which strengthens the importance of collecting multiple residue samples to better determine a tobacco lot’s CPA residue content.
A better understanding of CPA residue variances within and across cases may lead to more informed decisions in determining a tobacco lot’s acceptability.
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Acknowledgments
Emily Moyer and Brandie Garris, Global Laboratory Services, Inc.
Christian Rasmussen, Ioannis Kalampoukas, Onur Kuruoglu - Socotab Yaprak Tutun
2015
_AP
32_W
estb
erg.
AP
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A